2024 Q1 Form 10-Q Financial Statement

#000143774924001592 Filed on January 18, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $127.4M $121.7M
YoY Change -41.48%
Cost Of Revenue $111.7M $115.5M
YoY Change -31.36%
Gross Profit $15.72M $6.270M
YoY Change -84.24%
Gross Profit Margin 12.34% 5.15%
Selling, General & Admin $7.875M $6.367M
YoY Change -23.57%
% of Gross Profit 50.11% 101.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.866M $3.709M
YoY Change 5.7%
% of Gross Profit 24.6% 59.15%
Operating Expenses $7.875M $6.367M
YoY Change -23.57%
Operating Profit $7.840M -$97.00K
YoY Change -100.31%
Interest Expense $1.119M $29.00K
YoY Change -84.97%
% of Operating Profit 14.27%
Other Income/Expense, Net -$9.000K $22.00K
YoY Change -121.36%
Pretax Income $8.950M $1.555M
YoY Change -95.07%
Income Tax $2.011M $423.0K
% Of Pretax Income 22.47% 27.2%
Net Earnings $6.939M $1.132M
YoY Change -95.34%
Net Earnings / Revenue 5.45% 0.93%
Basic Earnings Per Share $0.36 $0.06
Diluted Earnings Per Share $0.35 $0.06
COMMON SHARES
Basic Shares Outstanding 19.45M 19.45M
Diluted Shares Outstanding 19.59M 19.57M

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $83.95M $85.62M
YoY Change 77.2%
Cash & Equivalents $83.95M $85.62M
Short-Term Investments
Other Short-Term Assets $6.803M $8.706M
YoY Change 12.83%
Inventory $92.53M $94.14M
Prepaid Expenses
Receivables $55.55M $43.35M
Other Receivables $872.0K $2.748M
Total Short-Term Assets $239.7M $231.8M
YoY Change -30.87%
LONG-TERM ASSETS
Property, Plant & Equipment $129.8M $129.3M
YoY Change 19.55%
Goodwill $9.745M $9.745M
YoY Change 0.0%
Intangibles $5.716M $5.903M
YoY Change -13.79%
Long-Term Investments
YoY Change
Other Assets $12.27M $13.80M
YoY Change 18.33%
Total Long-Term Assets $157.5M $158.8M
YoY Change 16.38%
TOTAL ASSETS
Total Short-Term Assets $239.7M $231.8M
Total Long-Term Assets $157.5M $158.8M
Total Assets $397.2M $390.6M
YoY Change -17.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.41M $23.85M
YoY Change -49.03%
Accrued Expenses $7.197M $9.585M
YoY Change -39.34%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $33.38M $33.44M
YoY Change -46.58%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $12.91M $23.54M
YoY Change 21.29%
Total Long-Term Liabilities $12.91M $23.54M
YoY Change 21.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $33.38M $33.44M
Total Long-Term Liabilities $12.91M $23.54M
Total Liabilities $56.61M $56.97M
YoY Change -30.52%
SHAREHOLDERS EQUITY
Retained Earnings $236.1M $230.0M
YoY Change -20.48%
Common Stock $104.8M $103.9M
YoY Change 2.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $340.6M $333.6M
YoY Change
Total Liabilities & Shareholders Equity $397.2M $390.6M
YoY Change -17.21%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $6.939M $1.132M
YoY Change -95.34%
Depreciation, Depletion And Amortization $3.866M $3.709M
YoY Change 5.7%
Cash From Operating Activities $1.377M $21.83M
YoY Change -331.19%
INVESTING ACTIVITIES
Capital Expenditures $1.957M $12.27M
YoY Change -436.2%
Acquisitions
YoY Change
Other Investing Activities -$247.0K -$114.0K
YoY Change -132.66%
Cash From Investing Activities -$2.204M -$12.38M
YoY Change 275.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $67.00K
YoY Change 0.0%
Cash From Financing Activities -843.0K -$49.51M
YoY Change 2394.06%
NET CHANGE
Cash From Operating Activities 1.377M $21.83M
Cash From Investing Activities -2.204M -$12.38M
Cash From Financing Activities -843.0K -$49.51M
Net Change In Cash -1.670M -$40.06M
YoY Change 171.95%
FREE CASH FLOW
Cash From Operating Activities $1.377M $21.83M
Capital Expenditures $1.957M $12.27M
Free Cash Flow -$580.0K $9.566M
YoY Change -265.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Gross Profit
GrossProfit
17786000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11809000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
46155000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
19853000 usd
CY2023Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0 usd
CY2023Q4 iiin Increase In Cash Surrender Value Of Life Insurance Policies Over Premiums Paid
IncreaseInCashSurrenderValueOfLifeInsurancePoliciesOverPremiumsPaid
675000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20070000 usd
CY2023Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9164000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-12921000 usd
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-28
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Entity Central Index Key
EntityCentralIndexKey
0000764401
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 pure
CY2022Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
6270000 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6367000 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7126000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22000 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3342000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
29000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
24000 usd
CY2023Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
1659000 usd
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
440000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1555000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14418000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
423000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3295000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
1132000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
11123000 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19497000
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19573000
CY2023Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.53
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1132000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
34346000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
19454000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
83832000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
278502000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-283000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
381505000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
447513000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
11123000 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3350000 usd
CY2022Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
16000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
130000 usd
CY2022Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1378000 usd
CY2023Q4 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
2404000 usd
CY2023Q4 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
20702000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21834000 usd
CY2023Q4 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
12268000 usd
CY2022Q4 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8200000 usd
CY2023Q4 iiin Increase In Cash Surrender Value Of Life Insurance Policies
IncreaseInCashSurrenderValueOfLifeInsurancePolicies
122000 usd
CY2022Q4 iiin Increase In Cash Surrender Value Of Life Insurance Policies
IncreaseInCashSurrenderValueOfLifeInsurancePolicies
81000 usd
CY2023Q4 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
3000 usd
CY2022Q4 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
9920000 usd
CY2023Q4 iiin Proceeds From Surrender Of Life Insurance Policies
ProceedsFromSurrenderOfLifeInsurancePolicies
5000 usd
CY2022Q4 iiin Proceeds From Surrender Of Life Insurance Policies
ProceedsFromSurrenderOfLifeInsurancePolicies
0 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12382000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1639000 usd
CY2023Q4 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
67000 usd
CY2022Q4 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
67000 usd
CY2023Q4 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
67000 usd
CY2022Q4 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
67000 usd
CY2023Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
49191000 usd
CY2022Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
39501000 usd
CY2023Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
20000 usd
CY2023Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
243000 usd
CY2022Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
94000 usd
CY2023Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
539000 usd
CY2022Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
916000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-49507000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-40323000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-40055000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5678000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
125670000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48316000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
85615000 usd
CY2023Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8000 usd
CY2022Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
187000 usd
CY2023Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1846000 usd
CY2022Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1520000 usd
CY2023Q4 iiin Restricted Stock Units And Stock Options Surrendered For Withholding Taxes Payable
RestrictedStockUnitsAndStockOptionsSurrenderedForWithholdingTaxesPayable
20000 usd
CY2022Q4 iiin Restricted Stock Units And Stock Options Surrendered For Withholding Taxes Payable
RestrictedStockUnitsAndStockOptionsSurrenderedForWithholdingTaxesPayable
0 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
381505000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
1132000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
310000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
398000 usd
CY2023Q4 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
539000 usd
CY2023Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
20000 usd
CY2023Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
49191000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
333595000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
389744000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
11123000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
94000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
130000 usd
CY2022Q4 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
916000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
121725000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
166899000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11730000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5827000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5903000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12070000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5980000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6090000 usd
CY2023Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
187000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
194000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
562000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
743000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
752000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
480000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
453000 usd
CY2023Q4 iiin Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
2900000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
411000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.68
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
8000
CY2023Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
41.86
CY2023Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
34000
CY2023Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
30.84
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
171000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
369000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.42
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y14D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3073000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
362000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
30.39
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y3D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
3030000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
216000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
28.98
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2148000 usd
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.272 pure
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.229 pure
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
10900000 usd
CY2023Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
7500000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
149000 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3000 usd
CY2023Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
13000 usd
CY2022Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
16000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19497000
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19525000
CY2023Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
76000
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
59000
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19573000
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19584000
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39000
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
94000
CY2008Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000 usd
CY2023Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
539000 usd
CY2023Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
19076
CY2022Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
916000 usd
CY2022Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
31654
CY2023Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
20700000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
43659000 usd
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
63735000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
305000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
311000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43354000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
63424000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
38123000 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
39341000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5264000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5852000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
50755000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
58113000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
94142000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
103306000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
3510000 usd
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
4043000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2748000 usd
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
2448000 usd
CY2023Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
2410000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8706000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
6453000 usd
CY2023Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
11378000 usd
CY2023Q3 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
10586000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2152000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1939000 usd
CY2023Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
163000 usd
CY2023Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
175000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
110000 usd
CY2023Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
111000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13803000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12811000 usd
CY2023Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
15151000 usd
CY2023Q3 us-gaap Land And Land Improvements
LandAndLandImprovements
15107000 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
56697000 usd
CY2023Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
56653000 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
214999000 usd
CY2023Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
198528000 usd
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
13065000 usd
CY2023Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
18019000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
299912000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
288307000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
170612000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
168293000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
129300000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
120014000 usd
CY2023Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
2906000 usd
CY2023Q3 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
2132000 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2279000 usd
CY2023Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
5082000 usd
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1367000 usd
CY2023Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1912000 usd
CY2023Q4 iiin Accrued Sales Allowance Reserves Current
AccruedSalesAllowanceReservesCurrent
1270000 usd
CY2023Q3 iiin Accrued Sales Allowance Reserves Current
AccruedSalesAllowanceReservesCurrent
745000 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
158000 usd
CY2023Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
268000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
187000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
550000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
484000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9585000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11809000 usd
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
11555000 usd
CY2023Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
11374000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
10891000 usd
CY2023Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
7543000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
23536000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
19853000 usd

Files In Submission

Name View Source Status
iiin-20231230_def.xml Edgar Link unprocessable
0001437749-24-001592-index-headers.html Edgar Link pending
0001437749-24-001592-index.html Edgar Link pending
0001437749-24-001592.txt Edgar Link pending
0001437749-24-001592-xbrl.zip Edgar Link pending
ex_614768.htm Edgar Link pending
ex_614769.htm Edgar Link pending
ex_614770.htm Edgar Link pending
ex_614771.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
iiin-20231230.xsd Edgar Link pending
iiin20231231_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
iiin-20231230_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
iiin-20231230_cal.xml Edgar Link unprocessable
iiin-20231230_pre.xml Edgar Link unprocessable
iiin20231231_10q_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending